玻璃酸钠联合通痹胶囊治疗踝骨关节炎临床观察(1)
【摘 要】目的:观察玻璃酸钠联合通痹胶囊治疗踝骨关节炎的临床疗效。方法:将74例踝骨关节炎患者随机分为治疗组38例和对照组36例,对照组采用玻璃酸钠踝关节腔穿刺注射治疗,治疗组在对照组的基础上加服通痹胶囊,两组均以5周为1个疗程,观察两组治疗前后临床疗效及AOFASI评分。结果:治疗组优18例,良12例,可5例,差3例,总有效率为94.74%;对照组优13例,良11例,可6例,差6例,总有效率为83.33%。两组比较,差异有统计学意义(P < 0.05)。治疗后,两组AOFAS评分较治疗前均有提高(P < 0.01),且治疗组优于对照组(P < 0.05)。结论:玻璃酸钠联合通痹胶囊治疗踝骨关节炎具有较好的临床疗效,对踝骨关节炎的治疗有一定临床意义。【关键词】 骨关节炎,踝;通痹胶囊;玻璃酸钠;临床疗效
doi:10.3969/j.issn.2095-4174.2015.08.006
【ABSTRACT】Objective:To observe the clinical effect of treating ankle osteoarthritis with sodium hyaluronate combing Tongbi Capsule (通痹胶囊).Methods:74 cases of ankle osteoarthritis were randomly divided into a treatment group (38 cases) and a control group (36 cases).The control group was treated with sodium hyaluronate injection in the ankle joint ......
您现在查看是摘要页,全文长 3351 字符。